1. Novartis gets US approval for $2.1 million gene therapy #AsiaNewsNetwork  Eleven Myanmar
  2. $2.1m Novartis gene therapy to become world's most expensive drug  The Guardian
  3. FDA approves $2M medicine, most expensive ever  Medical Xpress
  4. No Miracle Drug Should Cost $2.1 Million  Bloomberg
  5. Novartis now has the most expensive drug ever after getting US approval  The Local Switzerland
  6. View full coverage on Google News
The company said Zolgensma was a one-time treatment for spinal muscular atrophy, a disease that affects about 1 in 10,000 births and which results in death or the need for permanent ventilation by the age of two in 90 percent of cases. But the announcement comes as the administration of US President Donald Trump has vowed to tackle soaring drug costs. Novartis defended the pricing by saying that gene therapy was a transformative new type of treatment and was 50 percent cheaper than current treatments.The company said Zolgensma was a one-time treatment for spinal muscular atrophy, a disease that affects about 1 in 10,000 births and which results in death or the need for permanent ventilation by the age of two in 90 percent of cases. But the announcement comes as the administration of US President Donald Trump has vowed to tackle soaring drug costs. Novartis defended the pricing by saying that gene therapy was a transformative new type of treatment and was 50 percent cheaper than current treatments.

Novartis gets US approval for $2.1 million gene therapy #AsiaNewsNetwork | Eleven Media Group Co., Ltd

U.S. regulators approve gene therapy priced at $2.125 million US to treat a rare condition called spinal muscular atrophy.U.S. regulators approve gene therapy priced at $2.125 million US to treat a rare condition called spinal muscular atrophy.

The medicine, sold by the Swiss drugmaker Novartis, is a gene therapy that treats an inherited condition called spinal muscular atrophy.The medicine, sold by the Swiss drugmaker Novartis, is a gene therapy that treats an inherited condition called spinal muscular atrophy.

FDA approves most expensive medicine ever, priced at $2M per treatment | Globalnews.ca

Bloomberg - Are you a robot?

“A New Gene Therapy Treatment Could Save the Lives of Babies With Spinal Muscular Atrophy. But It Costs $2.1 Million, The Highest-Ever Price For A One-Time Treatment, by @Katie_Thomas https://t.co/YtWpey1GMR via @nytimes #SMA #Zolgensma”

André Picard on Twitter: "A New Gene Therapy Treatment Could Save the Lives of Babies With Spinal Muscular Atrophy. But It Costs $2.1 Million, The Highest-Ever Price For A One-Time Treatment, by @Katie_Thomas https://t.co/YtWpey1GMR via @nytimes #SMA #Zolgensma"

“FDA approves innovative gene therapy to treat pediatric patients with spinal muscular atrophy, a rare disease and leading genetic cause of infant mortality https://t.co/2rAVNeW5P6”

Liz Szabo on Twitter: "FDA approves innovative gene therapy to treat pediatric patients with spinal muscular atrophy, a rare disease and leading genetic cause of infant mortality https://t.co/2rAVNeW5P6"

“BIG APPROVAL: FDA approves Novartis' $2 million gene therapy for spinal muscular atrophy https://t.co/ZUmQ7gQiz3 via @berkeleyjr @AngelicaLavito”

Dawn Kopecki on Twitter: "BIG APPROVAL: FDA approves Novartis' $2 million gene therapy for spinal muscular atrophy https://t.co/ZUmQ7gQiz3 via @berkeleyjr @AngelicaLavito"

“NEW: The Food and Drug Administration approved Novartis' $NVS $2.13 million gene therapy for spinal muscular atrophy. Shares are trading 4% higher https://t.co/5n1HEz2KHH w/ @angelicalavito”

Berkeley Lovelace Jr on Twitter: "NEW: The Food and Drug Administration approved Novartis' $NVS $2.13 million gene therapy for spinal muscular atrophy. Shares are trading 4% higher https://t.co/5n1HEz2KHH w/ @angelicalavito"

Zolgensma was a one-time treatment for spinal muscular atrophy, a disease that affects about 1 in 10,000 births and which results in death or the need for permanent ventilation by the age of two in 90 percent of cases.Zolgensma was a one-time treatment for spinal muscular atrophy, a disease that affects about 1 in 10,000 births and which results in death or the need for permanent ventilation by the age of two in 90 percent of cases.

US approves world’s costliest drug to treat rare childhood disorder | world news | Hindustan Times

The Food and Drug Administration on Friday approved the most expensive drug in the world, a $2.1 million, one-time gene therapy for treatment of a rare disease that afflicts infants.The Food and Drug Administration on Friday approved the most expensive drug in the world, a $2.1 million, one-time gene therapy for treatment of a rare disease that afflicts infants.

Novartis: Just Approved Gene Therapy Drug Is World's Most Expensive At $2.1 Million

James Wilson, MD, PhD, recalls being struck by the devastating toll of rare diseases as a young physician in the 1980s. He set out on a path to correct the genes that cause these conditions, including spinal muscle atrophy (SMA), the most common inherited fatal disease in infants.James Wilson, MD, PhD, recalls being struck by the devastating toll of rare diseases as a young physician in the 1980s. He set out on a path to correct the genes that cause these conditions, including spinal muscle atrophy (SMA), the most common inherited fatal disease in infants.

Newly approved gene therapy for SMA is based on delivery vehicle discovered by Penn expert

ZURICH/NEW YORK - Swiss drugmaker Novartis on Friday won U.S. approval for its gene therapy Zolgensma for spinal muscular atrophy (SMA), the leading genetic cause of death in infants, and priced the one-time treatment at a record $2.125 million. ZURICH/NEW YORK - Swiss drugmaker Novartis on Friday won U.S. approval for its gene therapy Zolgensma for spinal muscular atrophy (SMA), the leading genetic cause of death in infants, and priced the one-time treatment at a record $2.125 million.

Novartis $2 million gene therapy for rare disorder is world's most expensive drug | ABS-CBN News

Read about how SMA's first approved gene therapy, Zolgensma, works to treat in infants and toddlers, and trials underway or planned for other patients.Read about how SMA's first approved gene therapy, Zolgensma, works to treat in infants and toddlers, and trials underway or planned for other patients.

How SMA's Zolgensma Works and and Trials Underway in Range of SMA Patients

Novartis puts $2 million-dollar price tag on new drug that may only be used by a few hundred patients each year. Novartis puts $2 million-dollar price tag on new drug that may only be used by a few hundred patients each year.

Two million dollars for a single dose of medicine? | News | Al Jazeera

Swiss pharmaceutical company Novartis on Friday announced it had received US regulatory approval for a gene therapy that treats a rare childhood disorder and has a price tag of $2.1 million, making it the most expensive drug in history. Swiss pharmaceutical company Novartis on Friday announced it had received US regulatory approval for a gene therapy that treats a rare childhood disorder and has a price tag of $2.1 million, making it the most expensive drug in history.

Novartis now has the most expensive drug ever after getting US approval - The Local

The US Food and Drug Administration said the drug's safety had been tested in an ongoing clinical trial.

Novartis gets US approval for $2.1 million gene therapy - World - DAWN.COM

The FDA today has made Zolgensma, a Novartis treatment for the rare genetic disease spinal muscular atrophy, the second approved gene therapy in the US.The FDA today has made Zolgensma, a Novartis treatment for the rare genetic disease spinal muscular atrophy, the second approved gene therapy in the US.

Xconomy: Second US Gene Therapy, Approved for Rare Muscle Disease, to Cost $2M

Subscribe to read | Financial Times

Gene therapy drug Zolgensma has become the world's most expensive drug, with the one-time treatment priced at $US2.1255 million ($A3 million). Swiss drugmaker...Gene therapy drug Zolgensma has become the world's most expensive drug, with the one-time treatment priced at $US2.1255 million ($A3 million). Swiss drugmaker...

World's most expensive drug costs $US2m | The Canberra Times